Transcat (TRNS) to Release Quarterly Earnings on Monday

Key Points

• Transcat (TRNS) is set to release its Q2 2026 earnings on October 27th, with analysts forecasting earnings of $0.44 per share and revenue of $79.512 million.
• In its previous quarter, Transcat reported earnings of $0.59 per share, exceeding expectations, with revenue of $76.42 million compared to a consensus estimate of $72.28 million.
• Analysts have recently upgraded Transcat's rating, with Zacks Research changing its stance from "hold" to "strong-buy", contributing to a consensus rating of "Moderate Buy" and an average target price of $112.20.

Transcat (NASDAQ:TRNS - Get Free Report) is expected to be issuing its Q2 2026 results before the market opens on Monday, October 27th. Analysts expect the company to announce earnings of $0.44 per share and revenue of $79.5120 million for the quarter. Parties are encouraged to explore the company's upcoming Q2 2026 earningoverview page for the latest details on the call scheduled for Tuesday, October 28, 2025 at 11:00 AM ET.

Transcat (NASDAQ:TRNS - Get Free Report) last released its earnings results on Wednesday, August 6th. The scientific and technical instruments company reported $0.59 earnings per share for the quarter, topping analysts' consensus estimates of $0.40 by $0.19. The company had revenue of $76.42 million during the quarter, compared to the consensus estimate of $72.28 million. Transcat had a return on equity of 6.66% and a net margin of 4.64%. On average, analysts expect Transcat to post $2 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Transcat Stock Performance

NASDAQ:TRNS opened at $69.25 on Monday. The business has a 50 day moving average of $77.07 and a 200 day moving average of $80.43. The company has a market capitalization of $645.41 million, a price-to-earnings ratio of 48.43 and a beta of 0.70. Transcat has a 1-year low of $67.56 and a 1-year high of $133.40. The company has a debt-to-equity ratio of 0.11, a current ratio of 2.92 and a quick ratio of 2.36.

Analyst Ratings Changes

Several analysts have weighed in on TRNS shares. Zacks Research upgraded Transcat from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, October 7th. HC Wainwright reiterated a "buy" rating and issued a $116.00 price objective on shares of Transcat in a research report on Friday, August 22nd. Lake Street Capital started coverage on Transcat in a research report on Thursday, July 10th. They issued a "buy" rating and a $105.00 price objective for the company. Finally, Weiss Ratings reiterated a "hold (c-)" rating on shares of Transcat in a research report on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and three have given a Hold rating to the company's stock. Based on data from MarketBeat.com, Transcat has a consensus rating of "Moderate Buy" and an average target price of $112.20.

Hedge Funds Weigh In On Transcat

A number of hedge funds and other institutional investors have recently made changes to their positions in TRNS. Lazard Asset Management LLC bought a new position in shares of Transcat during the second quarter valued at approximately $54,000. Tower Research Capital LLC TRC raised its holdings in shares of Transcat by 245.5% during the second quarter. Tower Research Capital LLC TRC now owns 1,123 shares of the scientific and technical instruments company's stock valued at $97,000 after acquiring an additional 798 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Transcat by 6.3% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 5,462 shares of the scientific and technical instruments company's stock valued at $407,000 after acquiring an additional 325 shares in the last quarter. JPMorgan Chase & Co. raised its holdings in shares of Transcat by 88.3% during the second quarter. JPMorgan Chase & Co. now owns 8,555 shares of the scientific and technical instruments company's stock valued at $735,000 after acquiring an additional 4,012 shares in the last quarter. Finally, BNP Paribas Financial Markets raised its holdings in shares of Transcat by 1,315.9% during the second quarter. BNP Paribas Financial Markets now owns 9,175 shares of the scientific and technical instruments company's stock valued at $789,000 after acquiring an additional 8,527 shares in the last quarter. Institutional investors own 98.34% of the company's stock.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.